BackCapricor Therapeutics Overview
Capricor Therapeutics Inc

Capricor Therapeutics Target Price

See Capricor Therapeutics's analyst price targets ($14) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.17

Average Target Price

$13.88232.7% upside

4 analysts in the last 4 months

High: $38 | Low: $3.5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-29Cantor Fitzgerald$3.516.1% downsideOpen
2026-07-28Industrial Alliance Securities$767.9% upsideOpen
2026-07-27Roth Capital$767.9% upsideOpen
2026-05-15Roth CapitalBoobalan Pachaiyappan$38811.3% upsideOpen
2026-03-13Cantor FitzgeraldKristen Kluska$621386.8% upsideOpen
2025-12-15UBS$501099% upsideOpen
2025-12-10Piper Sandler$45979.1% upsideOpen
2025-12-08Oppenheimer$541195% upsideOpen
2025-12-04Maxim Group$501099% upsideOpen
2025-12-03Industrial Alliance Securities$481051.1% upsideOpen
2025-12-03H.C. Wainwright$601338.8% upsideOpen
2025-11-11Roth CapitalBoobalan Pachaiyappan$13211.8% upsideOpen
2025-07-11Piper SandlerEdward Tenthoff$20379.6% upsideOpen
2025-07-11H.C. WainwrightJoseph Pantginis$24475.5% upsideOpen
2024-10-21Piper SandlerEdward Tenthoff$17.5319.7% upsideOpen
2024-10-14OppenheimerLeland Gershall$21.5415.6% upsideOpen
2024-09-25Maxim GroupJason McCarthy$12.5199.8% upsideOpen
2024-09-25H.C. WainwrightJoseph Pantginis$10139.8% upsideOpen
2024-09-17OppenheimerLeland Gershall$7.579.9% upsideOpen
2024-05-16OppenheimerLeland Gershall$767.9% upsideOpen

Capricor Therapeutics (CAPR) FAQ

The latest target price for CAPR is $14. Investors often review this figure alongside Capricor Therapeutics's historical trend and sector peers before judging valuation or financial health.

Capricor Therapeutics trades near $4.17 while the consensus target sits at $14 (232.7% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CAPR's target price ($14), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Capricor Therapeutics's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.